B. C. Millar

INTENSIVE TREATMENT OF MULTIPLE MYELOMA AND CRITERIA FOR COMPLETE REMISSION

Martin Gore, C. Viner, M Meldrum et al. · The Lancet · 1989 · 195 citations

Medicine, Hematology, Oncology +8

A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 × 106 CD34+ cells/kg be considered the minimum threshold?

Seema Singhal, R Powles, J Treleaven et al. · Bone Marrow Transplantation · 2000 · 112 citations

Medicine, Hematology, Cell Therapy +13

Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment

R Powles, Noopur Raje, B. C. Millar et al. · Bone Marrow Transplantation · 1997 · 65 citations

Medicine, Hematology, Oncology +8

Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation

Seema Singhal, R Powles, S Kulkarni et al. · Bone Marrow Transplantation · 2000 · 51 citations

Medicine, Hematology, Cell Therapy +10

Donor lymphocyte infusion for childhood acute lymphoblastic leukaemia relapsing after bone marrow transplantation

Ayad Atra, B. C. Millar, V Shepherd et al. · British Journal of Haematology · 1997 · 35 citations

Medicine, Hematology, Immunology +13